NOTCH1 and B-cell chronic lymphocytic leukemia: A number of other studies have also reported a higher frequency of Notch1 mutations in cases of CLL undergoing Richter transformation to aggressive DLBCL, and in patients refractory to fludarabine therapy, further highlighting the potential clinical relevance of the Notch pathway in this disease [101, 103].